Evidence map›Paper›PMID 35873591›Full record

ReviewFrontiers in pharmacology2022

Progress in Research on Antitumor Drugs and Dynamic Changes in Skeletal Muscles.

Ting Xu, Zhen-Hao Li, Ting Liu, Cai-Hong Jiang, Ya-Juan Zhang, Hui Li, Ying Jiang, Juan Zhao, Wen-Jing Guo, Jia-Yuan Guo and 6 more

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in pharmacology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 4 institutions in 1 country.

Ting XuOrdos Clinical College, Inner Mongolia Medical University, Ordos, China.
Zhen-Hao LiSchool of Public Health and Management, Wenzhou Medical University, Wenzhou, China.
Ting LiuDepartment of Medical Oncology, Ordos Central Hospital, Ordos, China.
Cai-Hong JiangDepartment of Medical Oncology, Ordos Central Hospital, Ordos, China.
Ya-Juan ZhangDepartment of Medical Oncology, Ordos Central Hospital, Ordos, China.
Hui LiDepartment of Medical Oncology, Ordos Central Hospital, Ordos, China.
Ying JiangDepartment of Medical Oncology, Ordos Central Hospital, Ordos, China.
Juan ZhaoDepartment of Medical Oncology, Ordos Central Hospital, Ordos, China.
Wen-Jing GuoDepartment of Medical Oncology, Ordos Central Hospital, Ordos, China.
Jia-Yuan GuoOrdos Clinical College, Inner Mongolia Medical University, Ordos, China.
Lu WangOrdos Clinical College, Inner Mongolia Medical University, Ordos, China.
Jia-Xuan LiOrdos Clinical College, Inner Mongolia Medical University, Ordos, China.
Jing ShenOrdos Clinical College, Baotou Medical College, Ordos, China.
Gao-Wa JinDepartment of Medical Oncology, Ordos Central Hospital, Ordos, China.
Ze-Wei ZhangState Key Laboratory of Oncology in South China, Department of Radiation Oncology, Sun Yat-sen University Cancer Center, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.
Quan-Fu LiDepartment of Medical Oncology, Ordos Central Hospital, Ordos, China.
Inner Mongolia Medical University · CNBaotou Medical College · CNSun Yat-sen University Cancer Center · CNWenzhou Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

antitumor therapychemotherapy drugsdynamic changesarcopeniatargeted drugs

Identifiers

PMID35873591
PMCPMC9298970
OpenAlexW4286631604

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.